DJIA 18,097.83 -105.54 -0.58%
NASDAQ 4,966.52 -13.38 -0.27%
S&P 500 2,097.62 -10.16 -0.48%
market minute promo

Repligen Corp (NASDAQ: RGEN)

24.97 0.06 (0.24%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RGEN $24.96 0.20%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $24.75
Previous Close $24.91
Daily Range $24.24 - $25.00
52-Week Range $12.04 - $26.89
Market Cap $817.1M
P/E Ratio 69.19
Dividend (Yield) $0.00 (0.0%)
Volume 94,617
Average Daily Volume 286,761
Current FY EPS $0.30

Sector

Healthcare

Industry

Drug Makers

Repligen Corp (RGEN) Description

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system. Website: http://www.repligen.com/

News & Commentary

3 Stocks to Get on Your Watchlist

A biopharmaceutical company with an upcoming FDA decision, a discount store attracting possible buyout interest, and a potentially overvalued life sciences company are this week's three must-watch stocks.

Repligen (RGEN) Upgraded From Hold to Buy

Five Tech Stocks with a Bright Future in 2015

5 Tech Stocks with a Bright Future in 2015

Repligen (RGEN) Showing Signs Of Being Strong And Under The Radar

Repligen (RGEN) Shares March Higher, Can It Continue? - Tale of the Tape

Repligen (RGEN) Shares March Higher, Can It Continue? - Tale of the Tape

RGEN Crosses Below Key Moving Average Level

Repligen's (RGEN) CEO Walter Herlihy on Q3 2014 Results - Earnings Call Transcript

Repligen (RGEN) Q3 2014 Results - Earnings Call Webcast

Amgen And Regeneron Reach All-Time Highs Together: Updates On Both Biotech Stalwarts

Regeneron Genetics Center Fully Operational, Announces New Collaborations And Key Appointments

See More RGEN News...

RGEN's Top Competitors

RGEN $24.97 (0.24%)
Current stock: RGEN
AMGN $158.88 (0.20%)
Current stock: AMGN
GILD $103.49 (0.68%)
Current stock: GILD
BIIB $415.74 (0.71%)
Current stock: BIIB